68Ga-PSMA-617
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 68Ga-PSMA-617, covering 2022-08-09 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging [Phase 2]